EHGO · Eshallgo Inc. Class A Ordinary Shares

Eshallgo Inc. successfully resolved a prolonged bid price deficiency through a significant capital restructuring strategy. The company initially received a non-compliance notice from Nasdaq on July 23, 2025, after its Class A ordinary shares traded below the required $1.00 minimum for 30 consecutive business days. While Nasdaq provided a standard 180-day cure period, the company failed to regain compliance by the initial deadline of January 19, 2026, necessitating a second 180-day extension granted on January 20, 2026, which extended the deadline to July 20, 2026. To definitively address the low share price, the Board of Directors and shareholders approved a 16-for-1 reverse stock split on April 10, 2026. The split took effect on the Nasdaq Capital Market on April 20, 2026. Consequently, the company's stock maintained a closing bid price of $1.00 or greater for ten consecutive business days from April 20, 2026, to May 1, 2026. On May 4, 2026, Nasdaq formally notified the company that it had regained compliance, securing its listing status and mitigating the risk of delisting for investors.